iStent® Trabecular Micro-Bypass Stent System
FDA premarket approval P080030/S023 · decided 2022-02-18
Approval details
- PMA number
- P080030
- Supplement
- S023
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- iStent® Trabecular Micro-Bypass Stent System
- Generic name
- Intraocular pressure lowering implant
- Applicant
- Glaukos Corporation
- Date received
- 2022-02-04
- Decision date
- 2022-02-18
- Days to decision
- 14 days
- Decision code
- OK30
- Product code
- OGO
- Advisory committee
- Ophthalmic
- Expedited review
- No
- Location
- Laguna Hills, CA
- Statement
- Change to the sampling plan for Limulus Amebocyte Lysate (LAL) endotoxin testing.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| iStent infinite Trabecular Micro-Bypass System, Model iS3 (K220032) | Glaukos Corporation | 2022-08-02 |